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SUMMARY
Objectives: Evaluate the production and the research collaborative network on Leishmaniasis in South America. Methods: A 
bibliometric research was carried out using SCOPUS database. The analysis unit was original research articles published from 2000 to 
2011, that dealt with leishmaniasis and that included at least one South American author. The following items were obtained for each 
article: journal name, language, year of publication, number of authors, institutions, countries, and others variables. Results: 3,174 
articles were published, 2,272 of them were original articles. 1,160 different institutional signatures, 58 different countries and 398 
scientific journals were identified. Brazil was the country with more articles (60.7%) and Oswaldo Cruz Foundation (FIOCRUZ) had 
18% of Brazilian production, which is the South American nucleus of the major scientific network in Leishmaniasis. Conclusions: 
South American scientific production on Leishmaniasis published in journals indexed in SCOPUS is focused on Brazilian research 
activity. It is necessary to strengthen the collaboration networks. The first step is to identify the institutions with higher production, 
in order to perform collaborative research according to the priorities of each country.
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INTRODUCTION
Leishmaniasis is considered a “neglected tropical disease” by the 
World Health Organization19, with a worldwide distribution affecting 
mainly tropical and developing countries. It is characterized by a variety 
of clinical conditions that include the visceral and tegumentary forms, the 
latter of which has two: cutaneous and mucocutaneous8,17. These are the 
most frequent forms in Latin America, where 66,941 cases of cutaneous 
leishmaniasis were reported per year, between 2004 and 2008, mostly in 
Brazil, Colombia and Peru2,6.
Though leishmaniasis is a public health problem in many Latin 
American countries, the production of scientific literature on this 
disease is concentrated in Brazil, in collaboration with institutes in the 
United States, United Kingdom and France1,16. This is despite many 
South American countries having included leishmaniasis among their 
national research priorities, in order to ensure the best possible use of 
their resources to develop policies, standards, scientific knowledge, and 
health technology for its control, prevention and treatment4,15. Within 
this context, identifying the institutions that presently contribute to the 
development of leishmaniasis research is necessary, particularly within 
the South American sector.
The first step for increasing and improving scientific production 
from a broad range of Latin American countries is to identify the 
research groups with the highest levels of production and identify their 
collaborative networks. 
The intention is to identify and characterize collaborative research 
networks and foster the exchange and transfer of technology and 
knowledge. This is particularly pressing in the wake of the formation of 
the Union of South American Nations (UNASUR; www.unasurg.org) 
and the UNASUR Network of National Institutes of Health (RINS), 
whose objectives are to strengthen the exchange of knowledge and 
develop cooperation programs. For these reasons, the aim of this study 
is to describe the characteristics of scientific collaborations, researching 
leishmaniasis in South American countries between 2000 and 2011, as 
shown by scientific publications, and to identify the primary collaborative 
networks at the regional level. Results will comprise an up-to-date 
reference of the institutions investigating leishmaniasis in the region.
METHODOLOGY
Design and study population: The bibliometric study that was 
conducted searched for and extracted publications in SCOPUS from 
2000 to 2011 which dealt with leishmaniasis and included at least one 
South American author. The SCOPUS database was selected because 
it included all MEDLINE journals and contained the largest collection 
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of Latin American journals5. Additionally, it registered the institutional 
affiliation of all authors, necessary for the analysis of collaborative 
networks. The database search was conducted in October, 2012.
Search strategy: Titles, abstracts and keywords were searched 
using the truncated word leishman*, in order to include the terms 
leishmania, leishmaniasis, and leishmaniosis. The search was limited 
to peer-reviewed, original research articles published within countries 
that make up the South American sector of the Latin American and 
Caribbean regions, according to the classification of the United Nations 
(twelve countries: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, 
Guyana, Paraguay, Peru, Suriname, Uruguay, and Venezuela) between 
2000 and 2011.
Manual revisions were carried out for each title and abstract, 
removing the revisions, reports/case series, short communications, 
letters to the editor, image galleries, and symposia. Articles that were 
not related to the topic of leishmaniasis (abstracts that mentioned the 
term leishman*) were also excluded. Two different authors performed 
the revision (FR and MM), and when doubts arose they were resolved 
by consensus, reviewing the article in extenso with a third author (CHS).
Variables: From each article, the following variables were obtained: 
journal name, language and year of publication. The years of publication 
were categorized into two sub-periods, 2000-2005 and 2006-2011. 
Methodological quality of the articles was not assessed. The journals’ 
impact factors were obtained from Journal Citation Reports (JCR) 2011.
The number of authors, institutions and countries that participated was 
identified for each article. Since the analysis focused on the collaboration 
between institutions, their names were corrected manually when they 
were incomplete, translated incorrectly, or contained typographical errors. 
Following a methodology described previously13, this methodology was 
complemented with a search on the web of the profile of the authors or the 
institutions address. In this way, the following variables were obtained:
- Author’s signature: Number of authors per article.
- Institutional signature: Institutional affiliation declared by the authors 
in the article - for which there may be more than one.
- Country’s signature: Country that the authors declare in their 
institutional signatures.
When the institutional signature included any ministry of health, it 
was only considered if no additional hospital, institute or other institution 
with legal autonomy was indicated. From this, the interinstitutional 
(participation by two or more institutional signatures in one article) and 
international (participation by two or more signatory countries in one 
article) collaboration were evaluated. No collaborations between authors 
were evaluated, as these present more variants (appearing differently in 
their articles or changed institutional affiliations within the same period) 
that would have biased our analysis.
Data analysis: Frequency and percentage analyses were performed 
using SPSS v17.0 statistical software. The most productive institutions 
and countries, the number of collaborations between them (signatures that 
are related to each other by the number of joint publications), the number 
of publications per year, and the journal with the most publications 
were determined. To contrast the number of articles produced by South 
American countries, the number of publications was compared with the 
estimated number of annual cases of visceral and cutaneous leishmania2 
and scientific/technological development indicators18.
To illustrate the collaborative networks, the Pajek v.3.0.2 visual 
representation program was used, applying the Kamada-Kawai algorithm. 
This allows graphing the entire network, weighing the collaboration 
intensities, in addition to being understandable intuitively14. Furthermore, 
three bibliometric indicators were obtained. They allow assessing the 
relationship of the institutions with collaborative networks, which are:
- Degree of collaboration: this indicates the number of collaborators, 
which is a measurement reflecting the degree of interinstitutional 
connection.
- Intermediation: this assesses the extent that an institution was in 
the middle or allowed the interconnection between other network 
members; therefore, it measures the access and control of information 
flows.
- Proximity: this reflects the closeness of each institution with the 
remaining members comprising the network, assessing the interactive 
capacity of its peers.
RESULTS
In the SCOPUS database, 3,174 publications were retrieved for the 
entire study period. Following the manual review of the title and abstract 
of each publication, 2,272 (71.6%) original articles entered into the 
analysis. The excluded items were 282 (8.9%) review articles, 113 (3.6%) 
case reports, 73 (2.3%) letters to the editor, 12 (0.4%) case series, nine 
(0.3%) short communications, three (0.1%) image galleries, three (0.1%) 
symposia, one (0.03%) conference abstract, and one (0.03%) thesis. 
Furthermore, 405 (12.8%) publications were excluded for addressing 
issues not related to leishmaniasis.
Scientific production per year: In absolute terms, the number of 
original articles increased, during the study period, from 87 original 
articles in 2000 to 293 in 2011 (Fig. 1). During the period from 2000 
to 2005, there were 749 articles (33.0%) published, while from 2006 to 
2011, this number grew to 1,519 (67.0%).
Publication language: English was the most common publication 
language (87.6%), followed by Portuguese (8.9%), Spanish (3.2%), 
French (0.2%), and German (0.04%). From 2000 to 2005, the 
Fig. 1 - Number of original articles on leishmaniasis produced by South American countries, 
2000-2011.
HUAMANÍ, C.; ROMANÍ, F.; GONZÁLEZ-ALCAIDE, G.; MEJIA, M.O.; RAMOS, J.M.; ESPINOZA, M. & CABEZAS, C. - South American collaboration in scientific publications on 
leishmaniasis: bibliometric analysis in SCOPUS (2000-2011). Rev. Inst. Med. Trop. Sao Paulo, 56(5): 381-90, 2014.
383
predominant language used in original leishmaniasis articles was English 
(92.3%), which decreased to 85.3% during the period from 2006 to 2011. 
In contrast, Portuguese was used in 5.5% of the articles from 2000 to 
2005, and then for 2006-2011, its use grew to 10.7%. As for Spanish, 
2.0% of the total articles from 2000 to 2005 appeared in said language, 
while for 2006-2011, the number grew to 3.8%. In absolute terms, the 
number of articles in Portuguese increased from 41 (2000-2005) to 162 
(2006-2011), while the number of articles in English increased from 691 
(2000-2005) to 1296 (2006-2011).
Journals of publication: The total number of articles appeared in 
398 scientific journals. Eight of them accounted for 32.3% of the articles 
on leishmaniasis. One-half of the South American scientific production 
was published in 21 journals, while the other half was scattered 
throughout 379 journals. The number of journals publishing only one 
article on leishmaniasis was 198. Forty-six journals contained 65.5% 
of the publications. The two journals publishing the most articles on 
leishmaniasis were Brazilian; Memórias do Instituto Oswaldo Cruz and 
Revista da Sociedade Brasileira de Medicina Tropical which together 
accounted for 11.2% of the articles throughout the entire study period. 
The journals with the highest impact factor were Clinical Infectious 
Diseases (9,154), Journal of Immunology (5,788), and the Journal of 
Antimicrobial Chemotherapy (5,068) (Table 1).
Number of authors and institutions: The median number of authors 
per article was six with an interquartile range from five to eight. The trend 
was five authors. There were 10 authors or fewer in 91.5% of the articles, 
0.4% of them had only one, 54.2% listed from two to six authors, and 
45.4% had seven or more. One article listed 101 authors. The median 
number of authors per article remained constant in all years.
Regarding the number of institutional affiliations per article, the 
median and trend was two. The interquartile range was from two to three, 
i.e., 50% of the articles had two or three affiliated institutions: 32.3% cited 
two different institutional affiliations and 22.8% cited three. Just under a 
quarter of the articles listed a single institution, while 20.7% listed four 
institutions or more. One article listed 24 collaborating institutions. The 
median number of institutions remained constant in all years.
Production per country: The identified institutions represented 
58 different countries. Twenty countries accounted for 97.7% of the 
signatures. Brazil was the country with the most signatures (60.7%), 
followed by the United States (7.1%), Venezuela (4.9%), and Colombia 
(4.4%). Fifteen countries registered a single institutional signature. 
Five countries registered two institutional signatures, another five had 
three signatures and three of the countries registered four institutional 
signatures. Two countries had five institutions represented, three countries 
registered six institutions, three countries had ten, and two countries 
registered twelve signatures. Table 2 compares the production by South 
American countries with the annual number of leishmaniasis cases and 
other scientific/technological development indicators.
Production per institution: The 2,272 original articles had 1,160 
different institutional signatures. Most institutions with higher quantities 
come from Brazil and include the Oswaldo Cruz Foundation (FIOCRUZ), 
with 11% of South American production and 18% of Brazilian 
production. It is followed by the University of São Paulo, the Federal 
University of Minas Gerais, the Federal University of Rio de Janeiro, and 
the Federal University of Bahia (Table 3). The top four institutions also 
have the highest degree of collaboration, working with more than 100 
different institutions, in addition to the highest values of intermediation 
and proximity to other network members.
Among the institutions with fewer than 100 articles, but with high 
values for degree of collaboration, intermediation and proximity are 
the Cayetano Heredia University, the London School of Hygiene and 
Tropical Medicine, and the University of Antioquia. Table 4 shows the 
non-South American countries and their institutions with the highest 
quantities of signatures for original articles on leishmaniasis produced 
by South American countries.
Collaborative networks: One large collaborative network was 
identified (Fig. 2) along with five smaller ones (Fig. 3). The largest 
network is centered on Brazilian institutions, whose production center 
is FIOCRUZ. This institution collaborates intensely with the five most 
productive institutions and collaborates independently with several 
institutions primarily in Brazil, the USA, and the United Kingdom. The 
largest network has two extensions, the first of which derives from the 
collaboration between the Federal University of Rio de Janeiro with 
the Venezuelan Institute for Scientific Research, which then integrates 
other Venezuelan institutions into the network. The second extension 
begins at the Evandro Chagas Institute of Brazil, followed by the London 
School of Hygiene and Tropical Medicine of the United Kingdom, and 
concludes with the Cayetano Heredia University of Peru (UPCH), which 
then integrates European institutions that are primarily Belgian. Beyond 
the Venezuelan and Peruvian collaboration in these large networks, no 
collaboration with other South American institutions is evident.
The five smaller collaborative networks are constituted by i) 
four Japanese universities, the Catholic University of Santiago de 
Guayaquil, and the Ministry of Public Health of Ecuador; ii) exclusively 
Argentinean institutions; iii) Venezuelan institutions for Scientific 
Research with the University of Wurzburg (Germany); iv) Colombian 
institutions (Del Valle University and International Center of Training 
and medical research-CIDEIM) with Yale University; and v) two 
Colombian universities.
DISCUSSION
Overall, collaborations between South American institutions 
have been reported in other studies12,13 as being intense and including 
all countries in the region. However, in the case of collaborations 
for leishmaniasis research, (with the exception of the collaboration 
between Brazil and Venezuela, and to a lesser extent with Peru), South 
American countries collaborate less intensively. Leishmaniasis research 
has characteristics that differentiate it from other diseases. Individuals 
affected by the disease are usually rural, low-income, and there is 
low incidence in European countries and the United States, where the 
predominant clinical form is visceral leishmaniasis17. Because of these 
characteristics, leishmaniasis is not considered a research priority in 
these countries, which reduces the potential for collaborative research 
with South American countries. Furthermore, pharmaceutical industry 
investment is low, thus new drugs with fewer side effects and lower 
toxicity are not being developed. These characteristics, among others, 
have led leishmaniasis to be characterized as a “forgotten disease” (also 
known as “neglected tropical disease”)11. 
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Table 1
Scientific journals containing two-thirds of the scientific articles published on leishmaniasis produced by South American countries, 2000-2011
N° Journal n % Country Impact Factor (2011)a
1 Memorias do Instituto Oswaldo Cruz 146 6.4 Brazil 2.147
2 Revista da Sociedade Brasileira de Medicina Tropical 109 4.8 Brazil 0.681
3 American Journal of Tropical Medicine and Hygiene 102 4.5 USA 2.592
4 Experimental Parasitology 83 3.7 USA 2.122
5 Veterinary Parasitology 78 3.4 Netherlands 2.579
6 Parasitology Research 77 3.4 Germany 2.149
7 Acta Tropica 73 3.2 Netherlands 2.722
8 Transactions of the Royal Society of Tropical Medicine and Hygiene 65 2.9 Netherlands 2.022
9 Vaccine 45 2.0 Netherlands 3.766
10 Molecular and Biochemical Parasitology 44 1.9 Netherlands 2.551
11 Cadernos de Saude Publica 37 1.6 Brazil 0.889
12 Antimicrobial Agents and Chemotherapy 34 1.5 USA 4.841
13 Revista do Instituto de Medicina Tropical de Sao Paulo 34 1.5 Brazil 1
14 Parasitology 33 1.5 UK 2.961
15 Infection and Immunity 29 1.3 USA 4.165
16 Journal of Medical Entomology 28 1.2 USA 1.762
17 PLoS Neglected Tropical Diseases 27 1.2 USA 4.716
18 Journal of Infectious Diseases 26 1.1 USA 6.41
19 Parasite Immunology 23 1.0 UK 2.601
20 Veterinary Immunology and Immunopathology 22 1.0 Netherlands 2.076
21 International Journal for Parasitology 20 0.9 UK 3.393
22 Brazilian Journal of Medical and Biological Research 19 0.8 Brazil 1.129
23 Journal of Parasitology 19 0.8 USA 1.405
24 Neotropical Entomology 19 0.8 Brazil 0.603
25 Microbes and Infection 18 0.8 Italy 3.101
26 Revista Brasileira de Parasitologia Veterinaria 18 0.8 Brazil 0.712
27 PLoS ONE 17 0.7 USA 4.716
28 Journal of Clinical Microbiology 16 0.7 USA 4.153
29 Journal of Ethnopharmacology 16 0.7 Ireland 3.014
30 Bioorganic and Medicinal Chemistry 15 0.7 UK 2.921
31 European Journal of Medicinal Chemistry 15 0.7 Italia 3.346
32 Annals of Tropical Medicine and Parasitology 14 0.6 UK 1.429
33 Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 14 0.6 Brazil 0.291
34 Journal of Immunology 13 0.6 USA 5.788
35 Parasitology International 13 0.6 Ireland 2.132
36 Tropical Medicine and International Health 13 0.6 UK 2.795
37 Anais Brasileiros de Dermatologia 12 0.5 Brazil 0.554
38 Infection 12 0.5 Germany 2.659
39 Journal of Venomous Animals and Toxins Including Tropical Diseases 12 0.5 Brazil 0.429
40 Revista de Saude Publica 12 0.5 Brazil 1.328
41 BMC Infectious Diseases 11 0.5 UK 3.118
42 Clinical Infectious Diseases 11 0.5 USA 9.154
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Table 1
Scientific journals containing two-thirds of the scientific articles published on leishmaniasis produced by South American countries, 2000-2011 (cont.)
Table 3
Bibliometric indicators of the institutions with the largest number of signatures in original articles on leishmaniasis produced by  
South American countries in SCOPUS, 2000-2011
Order Institution Country Papers (%) Degree Interm. 
x 100
Proximity 
x 100
1 Oswaldo Cruz Foundation/Fiocruz Brazil 652 (11.1) 315 33.1 53.7
2 Universidade de São Paulo Brazil 322 (5.5) 222 18.1 48.3
3 Universidade Federal de Minas Gerais Brazil 266 (4.5) 148 7.8 44.1
4 Universidade Federal do Rio de Janeiro Brazil 196 (3.4) 122 7.5 44.7
5 Universidade Federal da Bahia Brazil 126 (2.2) 98 2.9 42.0
6 Universidade Estadual Paulista Brazil 102 (1.7) 64 3.4 40.6
7 Instituto Evandro Chagas Brazil 98 (1.7) 74 1.8 41.7
8 Universidad Central de Venezuela Venezuela 89 (1.5) 80 6.1 40.4
9 Universidade Federal de Ouro Preto Brazil 82 (1.4) 58 1.1 40.0
10 Universidade Estadual de Maringá Brazil 76 (1.3) 35 1.6 39.9
11 Universidade Federal de São Paulo Brazil 72 (1.2) 59 1.7 42.5
12 Universidad Peruana Cayetano Heredia Peru 65 (1.1) 97 6.4 42.2
13 Universidad de Antioquia Colombia 61 (1.0) 68 5.5 41.7
Table 2 
Comparison of the production by South American countries with the number of annual cases of leishmaniasis and  
other indicators of scientific/technological development
N° Country Papers published CL cases/yeara VL cases/yeara RDE b (million dollars) RDE/GDP %b
1 Brazil 3552 26008 3481 20,237.6 1.07
2 Venezuela 285 2480 40 ND ND
3 Colombia 256 17420 60 600.6 0.16
4 Argentina 218 261 8 2,658.7 0.51
5 Peru 124 6405 - 238.1 0.15
6 Bolivia 44 2647 - ND 0.26
7 Ecuador 35 1724 - 145.9 0.15
8 Paraguay 19 431 48 20.1 0.20
CL. Cutaneous Leishmania, VL: Visceral Leishmania, RDE: Research and Development Expenditure, GDP: Gross domestic product. a Source: Alvar J, Velez ID, Bern 
C, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS one. 2012;7(5):e35671(Alvar et al. 2012). b UNESCO (2010) UNESCO Science Report. 
The Current Status of Science around the World.
N° Journal n % Country Impact Factor (2011)a
43 Journal of Antimicrobial Chemotherapy 11 0.5 UK 5.068
44 Biomedica 10 0.4 Colombia 0.545
45 Brazilian Journal of Pharmacognosy 10 0.4 Brazil 0.261
46 Phytomedicine 10 0.4 Germany 3.268
aImpact Factor by JCR 2011.
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Order Institution Country Papers (%) Degree Interm. 
x 100
Proximity 
x 100
14 Universidade Federal do Piauí Brazil 55 (0.9) 46 1.0 40.1
15 Universidade Estadual de Campinas Brazil 53 (0.9) 33 1.1 40.1
16 Universidade de Brasília Brazil 52 (0.9) 55 2.7 42.3
17 Centro Internacional de Entrenamiento e Investigaciones Médicas Colombia 51 (0.9) 50 3.1 39.8
18 Universidad de Los Andes Colombia 44 (0.8) 36 2.4 35.3
19 Universidade Federal do Maranhão Brazil 43 (0.7) 45 1.0 39.8
20 Universidade Federal do Rio Grande do Norte Brazil 41 (0.7) 50 1.3 40.0
21 Universidade Federal do Ceará, Fortaleza Brazil 40 (0.7) 29 0.7 38.1
22 London School of Hygiene and Tropical Medicine U.K. 38 (0.7) 93 4.3 43.9
23 Universidade Federal de Mato Grosso do Sul Brazil 38 (0.7) 28 0.8 37.5
24 Universidade Federal Fluminense Brazil 37 (0.6) 25 0.6 38.5
25 Universidade Federal de Pernambuco Brazil 35 (0.6) 41 2.0 39.8
26 Instituto Venezolano de Investigaciones Científicas Venezuela 32 (0.6) 32 2.3 38.7
27 Administración Nacional de Laboratorios e Institutos de Salud Argentina 30 (0.5) 50 3.6 39.3
28 National Institutes of Health USA 29 (0.5) 52 3.1 41.8
29 Universidad de Carabobo Venezuela 27 (0.5) 39 1.5 39.3
30 Instituto Adolfo Lutz Brazil 26 (0.4) 19 0.3 37.2
31 Kochi University, Kohasu Japan 26 (0.4) 34 1.2 31.2
32 University of California USA 26 (0.4) 39 1.2 41.1
33 University of Glasgow U.K. 25 (0.4) 42 0.9 41.1
34 Institut de Recherche pour le Développement France 24 (0.4) 44 2.6 39.1
35 Universidad Nacional de Colombia Colombia 24 (0.4) 29 2.0 38.3
36 Universidade Federal de Juiz de Fora Brazil 24 (0.4) 12 0.0 37.7
37 Universidade Federal do Espírito Santo Brazil 24 (0.4) 23 0.7 38.3
38 Universidade Federal do Triângulo Mineiro Brazil 23 (0.4) 23 0.7 38.1
39 Consejo Nacional de Investigaciones Científicas y Técnicas Argentina 22 (0.4) 59 2.7 37.4
40 University of Cambridge, Cambridge U.K. 22 (0.4) 42 1.1 41.7
41 Universidad Autónoma de Madrid Spain 21 (0.4) 26 1.0 39.5
42 Universidade Federal do Paraná Brazil 21 (0.4) 29 1.4 38.9
43 Universidade do Estado do Rio de Janeiro Brazil 21 (0.4) 21 0.4 38.9
44 University of Washington USA 21 (0.4) 69 2.0 42.5
45 Escola Bahiana de Medicina e Saúde Pública Brazil 20 (0.3) 21 0.1 37.5
46 Universidad de Buenos Aires Argentina 20 (0.3) 25 0.7 32.0
47 Universidade Federal do Pará Brazil 20 (0.3) 24 0.2 38.6
48 University of Iowa USA 19 (0.3) 34 0.4 39.5
49 University of Texas USA 19 (0.3) 35 3.0 41.5
Table 3
Bibliometric indicators of the institutions with the largest number of signatures in original articles on leishmaniasis produced by  
South American countries in SCOPUS, 2000-2011 (cont.)
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Table 4
Non-South American countries with the largest number of signatures in original articles on leishmaniasis produced by South American countries, 2000-2011
Country Frequency % Institutions with more productiona
USA 415 7.1 NIH (29), Univ. California (26), Univ. Washington (21)
UK 206 3.5 London School of Hygiene and Tropical Medicine (38), Univ. Glasgow (25), Univ. Cambridge (22)
France 111 1.9 Institut de Recherche pour le Développement (24), Univ. Toulouse (9), Univ. Paris-Sud (7)
Spain 111 1.9 Univ. Autónoma de Madrid (21), Instituto de Parasitología y Biomedicina Lopez-Neyra (14), Insti-
tuto de Salud Carlos III (11)
Japan 75 1.3 Univ. Kochi (26), Univ. of the Ryukyus (17), Univ. Yamaguchi (11)
Germany 68 1.2 Univ. Wurzburg (14), Charité Univ. Med (4)
Belgium 52 0.9 Institute of Tropical Medicine (16), Institut Prince Leopold (15), Univ. Antwerp (7)
Canada 50 0.9 Univ. MacGill (9), Univ. Laval (7), Centre de Recherche en Infectiologie (5)
Switzerland 46 0.8 Word Health Organization (12), Univ. Geneva (11), Swiss Tropical and Public Health Institute (6)
Italy 20 0.3 Univ. degli Studi di Bari (6) b
Netherland 15 0.3 Royal Tropical Institute (7) b
Mexico 14 0.2 Centro de Investigación Científica de Yucatán (3)
a
 Only three institutions with the largest number of articles. b Other institutions have only one article.
Fig. 2 - Primary South American collaborative network for the production of research articles on leishmaniasis.
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The forgotten disease condition for leishmaniasis is exemplified 
in Peru, for example, by the very active collaborations that Cayetano 
Heredia University has with more than ten North American institutions 
in cancer research and with more than 20 institutions in clinical medicine 
research13, while the collaboration intensity with North American 
institutions is lower. Although leishmaniasis research is a specific area 
of development and can be carried out by fewer institutions, this does 
not mean that they are to be isolated from other foreign collaborators 
and institutions. On the contrary, as there are few national institutions 
researching it, collaborative work is needed (especially with foreign 
institutions), in order to increase their production.
Peruvian-Belgian collaboration, specifically that between the UPCH 
and the Institute of Tropical Medicine (Amberes, Belgium), has been 
described in its constitution, importance, and products9, by which the 
network described in our study reflects the results of such collaboration, 
which mainly comprises exchanges of researchers following training 
grants10. Although studies showing the products of the collaboration 
between South American institutions with other countries have not been 
found yet, the Peruvian example (Peruvian-Belgian collaboration) may 
explain the results of the specific cooperation between Ecuador and Japan.
Brazil leads in the South American context, participating in more 
than 50% of the South American scientific production12, and is the 
country with most cases in the region. Its investment in development, 
science and technology, along with its research policies, has allowed 
it to address its own health problems and require less collaboration to 
maintain and increase its scientific production. In the area of neglected 
diseases, it leads South American research7 in Chagas disease following 
collaboration patterns similar to those described in our study. There are 
three factors that make Brazil the country with the highest production 
on leishmaniasis and, perhaps, also with other neglected diseases: i) the 
high number of new cases of cutaneous and visceral leishmaniasis2; ii) 
increased public spending in research & development (the most in South 
America)18; and iii) an active network of interinstitutional collaboration, 
something which increases research productivity3. 
Globally, India leads scientific production on leishmaniasis. 
Following it are Brazil, Spain, the USA, and France1,16, however, the 
clinical form studied most is the visceral variety, which may explain 
why the remaining South American countries, which have a lower 
incidence of these clinical forms2, have less European or North American 
collaboration. The collaboration between these countries is focused in 
priority topics for European countries and the USA, and not in complete 
response to the research agendas of the South American countries. Theses 
agendas in several cases include neglected infectious diseases but those 
not prioritize leishmaniasis as a specific cause of disease burden. In 
this context, participation by UNASUR could play an integrating role 
in the promotion of research efforts within South America. The RINS-
UNASUR 2011-2015 five-year plan establishes the coordination of 
projects through the creation of thematic networks composed of staff 
members from UNASUR member countries with recognized expertise in 
the field of study on both national institutes of health, as well as university 
levels in these countries. One of the main proposed thematic networks 
is research on neglected infectious diseases. This initiative could focus 
research efforts on leishmaniasis, which, like dengue fever, is widespread 
throughout the region. It would also strengthen the leishmaniasis 
collaborative network on a regional level. The results of this study could 
serve as a baseline diagnosis to be used for comparison purposes, once 
the specified measures envisaged in the five-year plan materialize.
As for the distribution of the published articles, our sample 
appeared in almost 400 different journals. However, 32.3% of them 
are concentrated in only eight journals. Another research has reported 
Fig. 3 - Smaller South American collaborative networks for the production of research articles on leishmaniasis.
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the top eight journals accounting for 21% and 24% of the articles on 
leishmaniasis16. Seventy percent of the articles are distributed throughout 
390 different journals. This nucleus of eight journals is comprised by 
two that are Brazilian (and are those that published the most) while 
the remaining six are not South American. Both Brazilian journals are 
institutional - Memórias do Instituto Oswaldo Cruz and the Revista da 
Sociedade Brasileira de Medicina Tropical belong to a public research 
institute and a medical society, respectively. They publish research on 
tropical diseases, preventive medicine, public health, and infectious 
diseases. Furthermore, both journals are free, which improves their 
visibility within the South American scientific community. If these results 
are compared with another study that explores worldwide production 
over a similar period of time (2000-2009), we can find some differences 
that can be explained by the geographic limits in our study. In that study, 
the journals with the highest publication of articles on leishmaniasis 
were Molecular and Biochemical Parasitology, Infection and Immunity, 
Experimental Parasitology, The American Journal of Tropical Medicine 
and Hygiene, and Parasitology Research. Although it is true that these 
journals are found among those with the most publications in our analysis, 
the order according to contribution is clearly different.
This study has some limitations. Our sample does not represent all the 
South American collaboration or actions taken to address the problems 
associated with leishmaniasis, as this may be reflected differently from 
a scientific publication (patents, clinical guidelines, among others)11. 
For example, the scientific production described does not represent the 
region’s entire production, only research appearing in journals with 
international visibility. Therefore, it is possible that articles have been 
published about leishmaniasis in local journals that are not indexed by 
SCOPUS or MEDLINE. However, we felt that not including them would 
not affect our analysis of collaborative networks given that the production 
in local journals is less and because that research is conducted with less 
international collaboration. The IF was obtained from 2011 by JCR. This 
IF does not represent the whole period, but it is necessary to understand 
the current importance of the journals. Finally, it is possible that networks 
under construction are not evident in our network, since they still have 
to publish enough articles together. These will be revealed in subsequent 
studies, with our study serving as a baseline.
In conclusion, South American scientific production on leishmaniasis 
published in journals indexed in SCOPUS is focused on Brazilian activity. 
This activity integrates several institutions that collaborate primarily with 
FIOCRUZ and integrate Venezuelan and Peruvian institutions, but with 
little foreign participation, especially from South American countries. 
Networks producing less are those integrated by Ecuadorian-Japanese 
collaboration, or Venezuelan, Colombian or Argentinean institutions. It is 
possible that the South American collaborative networks will integrate the 
research factors from several countries as part of RINS-UNASUR soon, 
so we recommend that institutions interested in conducting or increasing 
their scientific production on leishmaniasis promote collaboration with 
the institutions nearest the center of these networks, i.e., those that 
demonstrate the highest values in collaboration and intermediation. All 
this considering that leishmaniasis is more than a neglected disease, it is 
a disease of forgotten or excluded populations, and finding solutions for 
its treatment (new and more effective drugs), prevention and control will 
only be possible by the attention paid and initiative shown by affected 
countries, providing the necessary funding and favoring collaborative 
work on a common problem. 
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RESUMEN
Colaboración Sudamericana en publicaciones científicas sobre 
leishmaniasis: análisis bibliométrico en SCOPUS (2000-2011)
Objetivos: Evaluar la producción y la red de colaboración de 
investigación sobre leishmaniasis en Sudamérica. Métodos: Se realizó 
un estudio bibliométrico usando la base de datos SCOPUS. La unidad 
de análisis fueron los artículos originales de investigación publicados 
desde el año 2000 hasta 2011, realizados sobre leishmaniasis y que 
incluyeron al menos un autor sudamericano. Se obtuvieron para cada 
artículo: nombre de la revista, idioma, año de publicación, número 
de autores, instituciones, países y otras variables. Resultados: 3174 
artículos fueron publicados, 2.272 de ellos eran artículos originales. 
Se identificaron 1.160 firmas institucionales diferentes, 58 países y 
398 revistas científicas. Brasil fue el país con más artículos (60,7%) y 
la Fundación Oswaldo Cruz (FIOCRUZ) tuvo 18% de la producción 
brasileña, convirtiéndose en el núcleo Sudamericano de la mayor red 
científica de Leishmaniasis. Conclusiones: La producción científica 
de Sudamérica sobre Leishmaniasis publicada en revistas indexadas 
en SCOPUS se centra en la actividad de la investigación brasileña. Es 
necesario fortalecer las redes de colaboración, el primer paso para ello 
es la identificación de las instituciones con mayor producción con el 
fin de llevar a cabo la investigación en colaboración de acuerdo con las 
prioridades de cada país.
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